Literature DB >> 12969936

Teleoanalysis: combining data from different types of study.

Nicholas J Wald1, Joan K Morris.   

Abstract

Mesh：

Year:  2003        PMID： 12969936      PMCID： PMC194099          DOI： 10.1136/bmj.327.7415.616

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  Neural-tube defects.

Authors:  L D Botto; C A Moore; M J Khoury; J D Erickson
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

Review 2.  Quantifying the effect of folic acid.

Authors:  N J Wald; M R Law; J K Morris; D S Wald
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

Review 3.  Folic acid and the prevention of neural tube defects.

Authors:  N Wald
Journal:  Ann N Y Acad Sci       Date:  1993-03-15       Impact factor: 5.691

Review 4.  Dietary fat intake and prevention of cardiovascular disease: systematic review.

Authors:  L Hooper; C D Summerbell; J P Higgins; R L Thompson; N E Capps; G D Smith; R A Riemersma; S Ebrahim
Journal:  BMJ       Date:  2001-03-31

5.  Folate levels and neural tube defects. Implications for prevention.

Authors:  L E Daly; P N Kirke; A Molloy; D G Weir; J M Scott
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

6.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

7.  Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.

Authors:  M R Law; N J Wald; T Wu; A Hackshaw; A Bailey
Journal:  BMJ       Date:  1994-02-05

Review 8.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321
  8 in total
  14 in total

1.  Systematic review to support the development of nutrient reference intake values: challenges and solutions.

Authors:  Mei Chung; Ethan M Balk; Stanley Ip; Jounghee Lee; Teruhiko Terasawa; Gowri Raman; Thomas Trikalinos; Alice H Lichtenstein; Joseph Lau
Journal:  Am J Clin Nutr       Date:  2010-05-26       Impact factor: 7.045

2.  A manifesto for clinical pharmacology from principles to practice.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 3.  Anecdotes that provide definitive evidence.

Authors:  Jeffrey K Aronson; Manfred Hauben
Journal:  BMJ       Date:  2006-12-16

4.  Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?

Authors:  Jeremy Howick; Paul Glasziou; Jeffrey K Aronson
Journal:  J R Soc Med       Date:  2009-05       Impact factor: 5.344

6.  Adverse drug reactions.

Authors:  Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

7.  Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).

Authors:  Manfred Hauben; Lester Reich; Charles M Gerrits; David Madigan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Evaluating the causal relevance of diverse risk markers: horizontal systematic review.

Authors:  Hannah Kuper; Amanda Nicholson; Mika Kivimaki; Amina Aitsi-Selmi; Gianpiero Cavalleri; John E Deanfield; Peter Heuschmann; Xavier Jouven; Sofia Malyutina; Bongani M Mayosi; Susanna Sans; Troels Thomsen; Jacqueline C M Witteman; Aroon D Hingorani; Debbie A Lawlor; Harry Hemingway
Journal:  BMJ       Date:  2009-11-05

9.  A journey into clinical evidence: from case reports to mixed treatment comparisons.

Authors:  G Biondi-Zoccai; G Landoni; M G Modena
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2011

Review 10.  Systematic reviews of adverse effects: framework for a structured approach.

Authors:  Yoon K Loke; Deirdre Price; Andrew Herxheimer
Journal:  BMC Med Res Methodol       Date:  2007-07-05       Impact factor: 4.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.